Role of DNA mismatch repair defects in the pathogenesis of human cancer.
By P. Peltomäki. Journal of Clinical Oncology, 2003
723 citations recorded by the source corpus.
Subfields: Genetics, Oncology, Pathology and Forensic Medicine
View Paper: https://www.semanticscholar.org/paper/e69046c98a49ec400c50adb5a43470e95c5d72b0
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Genetics
In Oncology
In Pathology and Forensic Medicine
Citations in the corpus
- The multifaceted mismatch-repair system (2006, background): “jpg" NDATA ITEM> ]> Over the past decade, a significant proportion of cancers of the colon, endometrium and other organs were found to exhibit a phenotype known as microsatellite instability (MSI; see Ref”
- Mismatch repair status and BRAF mutation status in metastatic colorectal cancer patients: a pooled analysis of the CAIRO, CAIRO2, COIN and FOCUS studies (2014, neutral): “It has been suggested that a greater immunoreactivity of dMMR tumors (29, 30) or decreased tumor cell viability due to excessive DNA damage (31) may play a role.”
- Large-scale clinical interpretation of genetic variants using evolutionary data and deep learning (2020, background): “Similarly, variants in MSH2 and MSH6 of the mismatch DNA repair complex are associated with hereditary nonpolyposis colorectal cancer 51 and with ~20% of sporadic cancers 52 , but only 4% of observed variants have clinical labels (Extended Data Table 1).”